Advancing the Use of Patient Preference Information as Scientific Evidence in Medical Product Evaluation: A Summary Report of the Patient Preference Workshop

Patient. 2019 Dec;12(6):553-557. doi: 10.1007/s40271-019-00396-5.

Heather L Benz^{1

2}, Ting-Hsuan Joyce Lee³, Jui-Hua Tsai^{4

5

6}, John F P Bridges^{4

5

7}, Sara Eggers⁸, Megan Moncur^{8

9}, Fadia T Shaya¹⁰, Ira Shoulson¹¹, Erica S Spatz¹², Leslie Wilson¹³, Anindita Saha³

¹ FDA Center for Devices and Radiological Health, Silver Spring, MD, USA. heather.benz@fda.hhs.gov.
² FDA Center for Biologics Evaluation and Research, Silver Spring, MD, USA. heather.benz@fda.hhs.gov.
³ FDA Center for Devices and Radiological Health, Silver Spring, MD, USA.
⁴ Johns Hopkins University Center of Excellence in Regulatory Science and Innovation, Baltimore, MD, USA.
⁵ Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.
⁶ Pharmerit International, Bethesda, USA.
⁷ Ohio State University, Columbus, USA.
⁸ FDA Center for Drug Evaluation and Research, Silver Spring, MD, USA.
⁹ FDA Center for Biologics Evaluation and Research, Silver Spring, MD, USA.
¹⁰ University of Maryland Center of Excellence in Regulatory Science and Innovation, Baltimore, MD, USA.
¹¹ Georgetown University Center of Excellence in Regulatory Science and Innovation, Washington, DC, USA.
¹² Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation, New Haven, CT, USA.
¹³ UCSF-Stanford Center of Excellence in Regulatory Science and Innovation, San Francisco, CA, USA.

No abstract available

Publication types